Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 11:46 PM
Study NCT ID:
NCT01526694
Status:
COMPLETED
Last Update Posted:
2018-07-03
First Post:
2012-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM
Sponsor:
Azienda Ospedaliera di Bolzano
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-27
First Submit QC Date:
None
Study First Post Date:
2012-02-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-02
Last Update Post Date:
2018-07-03
Last Update Post Date Type:
ACTUAL